SUZI SHERO: Open Payments
NPI 1578298618 · ROARING SPRING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 21 payments from 11 companies in 2025. Trend: 2023 $106 · 2024 $832 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $54 |
| Novo Nordisk Inc | 2 | $52 |
| Astellas Pharma US Inc | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Exact Sciences Corporation | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: ZEPBOUND, Kerendia, Wegovy, Veozah, CAPLYTA, Auvelity, Cologuard Collection Kit, REXULTI.
Industry payments across PA — which companies pay providers there.
